PortfoliosLab logo
American Oncology Network Inc. (AONC)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

IPO Date

May 5, 2021

Highlights

Market Cap

$190.11M

EPS (TTM)

-$0.89

Total Revenue (TTM)

$1.40B

Gross Profit (TTM)

$108.46M

EBITDA (TTM)

$17.62M

Year Range

$1.01 - $6.80

Short %

0.39%

Short Ratio

0.63

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in American Oncology Network Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%40.00%December2025FebruaryMarchAprilMay
-37.50%
35.90%
AONC (American Oncology Network Inc.)
Benchmark (^GSPC)

Returns By Period

American Oncology Network Inc. (AONC) returned 18.58% year-to-date (YTD) and 61.73% over the past 12 months.


AONC

YTD

18.58%

1M

30.15%

6M

96.72%

1Y

61.73%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.70%

1M

13.67%

6M

-5.18%

1Y

9.18%

5Y*

14.14%

10Y*

10.43%

*Annualized

Monthly Returns

The table below presents the monthly returns of AONC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20254.60%-0.62%-4.94%26.00%-4.76%18.58%
2024-10.34%12.85%-8.04%-30.42%-12.57%-68.56%166.67%29.93%7.20%-20.26%39.87%16.32%-14.24%
20230.75%0.79%1.47%-1.26%0.49%0.49%2.91%-0.94%-11.60%-34.68%18.19%-17.83%-41.26%
2022-0.62%0.26%0.46%0.20%0.05%-0.05%0.41%-0.10%0.10%1.22%-0.00%1.06%3.03%
20210.94%0.52%-0.41%-0.93%0.94%0.21%0.31%-0.00%1.56%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AONC is 74, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of AONC is 7474
Overall Rank
The Sharpe Ratio Rank of AONC is 6969
Sharpe Ratio Rank
The Sortino Ratio Rank of AONC is 7878
Sortino Ratio Rank
The Omega Ratio Rank of AONC is 7878
Omega Ratio Rank
The Calmar Ratio Rank of AONC is 7474
Calmar Ratio Rank
The Martin Ratio Rank of AONC is 7272
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for American Oncology Network Inc. (AONC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The current American Oncology Network Inc. Sharpe ratio is 0.45. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of American Oncology Network Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00December2025FebruaryMarchAprilMay
0.45
0.48
AONC (American Oncology Network Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


American Oncology Network Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-79.31%
-7.82%
AONC (American Oncology Network Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the American Oncology Network Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the American Oncology Network Inc. was 96.38%, occurring on Jun 28, 2024. The portfolio has not yet recovered.

The current American Oncology Network Inc. drawdown is 79.31%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.38%Sep 19, 2023196Jun 28, 2024
-7.25%May 14, 20211May 14, 2021457Mar 9, 2023458
-2.76%Mar 10, 202315Mar 30, 202382Jul 28, 202397
-2.46%Sep 14, 20231Sep 14, 20231Sep 15, 20232
-1.41%Aug 3, 202315Aug 23, 202314Sep 13, 202329

Volatility

Volatility Chart

The current American Oncology Network Inc. volatility is 27.33%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%December2025FebruaryMarchAprilMay
27.33%
11.21%
AONC (American Oncology Network Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of American Oncology Network Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of American Oncology Network Inc., comparing actual results with analytics estimates.


-1.00-0.500.00AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024
-1.22
0
Actual
Estimate

Valuation

The Valuation section provides an overview of how American Oncology Network Inc. is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for AONC relative to other companies in the Medical Care Facilities industry. Currently, AONC has a P/S ratio of 0.1. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for AONC in comparison with other companies in the Medical Care Facilities industry. Currently, AONC has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items